Skip to main content
Market intelligence
NUVLHealthcare

Nuvalent Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 9, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 9, 2026Darlene NociChief Development OfficerSale20,000$122.81$2,456,200
Jun 8, 2026James Richard PorterPresident and CEOSale30,000$88.53$2,656,005
Jun 1, 2026Alexandra BalcomChief Financial OfficerSale11,430$98.69$1,128,080